{"name": "InVivo Therapeutics",
 "permalink": "invivo-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/invivo-therapeutics",
 "homepage_url": "http://www.invivotherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@invivotherapeutics.com",
 "phone_number": "617-475-1520",
 "description": "",
 "created_at": "Thu Sep 16 04:08:23 UTC 2010",
 "updated_at": "Wed Jun 05 19:21:55 UTC 2013",
 "overview": "\u003Cp\u003EInVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of research initiated in the\nlaboratories of Robert Langer, PhD, of the Massachusetts Institute of Technology, Jay Vacanti, MD, of the Massachusetts General and Children\u00e2\u20ac\u2122s Hospitals in Boston, and Yang Teng, PhD, MD, of Harvard\u0026#8217;s Brigham and Women\u0026#8217;s Hospital.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       68],
      "assets/images/resized/0010/1940/101940v1-max-150x150.png"],
     [[168,
       77],
      "assets/images/resized/0010/1940/101940v1-max-250x250.png"],
     [[168,
       77],
      "assets/images/resized/0010/1940/101940v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Frank",
      "last_name": "Reynolds",
      "permalink": "frank-reynolds",
      "image": null}},
   {"is_past": false,
    "title": "Chief Science Officer",
    "person":
     {"first_name": "Christopher",
      "last_name": "Pritchard",
      "permalink": "christopher-pritchard",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Sean",
      "last_name": "Moran",
      "permalink": "sean-moran",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$10.5M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.masshightech.com/stories/2010/10/25/daily28-InVivo-Therapeutics-raises-105M-completes-reverse-merger.html",
    "source_description": "InVivo Therapeutics raises $10.5M, completes reverse merger",
    "raised_amount": 10500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 27,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "One Broadway, 14th Floor",
    "address2": "",
    "zip_code": "02142",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "announces new CFO",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 27,
    "source_url": "http://www.masshightech.com/stories/2010/09/27/daily9-InVivo-Therapeutics-names-Moran-as-new-CFO.html",
    "source_text": null,
    "source_description": "InVivo Therapeutics names Moran as new CFO",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "InVivo Therapeutics",
      "permalink": "invivo-therapeutics"}},
   {"description": "has signed a lease to open its first manufacturing and development facility in Medford",
    "stoned_year": 2010,
    "stoned_month": 11,
    "stoned_day": 2,
    "source_url": "http://www.masshightech.com/stories/2010/11/01/daily12-InVivo-Therapeutics-opens-Medford-facility.html",
    "source_text": null,
    "source_description": "InVivo Therapeutics opens Medford facility",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "InVivo Therapeutics",
      "permalink": "invivo-therapeutics"}},
   {"description": "its previously announced $10.5 million private placement actually brought in $13 milion ",
    "stoned_year": 2010,
    "stoned_month": 12,
    "stoned_day": 6,
    "source_url": "http://www.masshightech.com/stories/2010/12/06/daily4-InVivo-exceeds-private-placement-by-25M.html",
    "source_text": null,
    "source_description": "InVivo exceeds private placement by $2.5M",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "InVivo Therapeutics",
      "permalink": "invivo-therapeutics"}},
   {"description": "has appointed George Nolen, former Siemens Corp. president and CEO, as lead director of the Cambridge developer of therapeutics for spinal cord injuries",
    "stoned_year": 2010,
    "stoned_month": 12,
    "stoned_day": 13,
    "source_url": "http://www.masshightech.com/stories/2010/12/13/daily10-Nolen-named-InVivo-lead-director.html",
    "source_text": null,
    "source_description": "Nolen named InVivo lead director",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "InVivo Therapeutics",
      "permalink": "invivo-therapeutics"}},
   {"description": "they have a strategic research collaboration to develop novel treatments for spinal cord injuries by combining their therapeutic approaches",
    "stoned_year": 2011,
    "stoned_month": 5,
    "stoned_day": 4,
    "source_url": "http://www.masshightech.com/stories/2011/05/02/daily37-InVivo-Therapeutics-Miami-Project-to-co-develop-spinal-cord-injury-treatments.html",
    "source_text": null,
    "source_description": "InVivo Therapeutics, Miami Project to co-develop spinal cord injury treatments",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "InVivo Therapeutics",
      "permalink": "invivo-therapeutics"}},
   {"description": "InVivo Therapeutics scientist gets $10K grant",
    "stoned_year": 2012,
    "stoned_month": 8,
    "stoned_day": 22,
    "source_url": "http://www.masshightech.com/stories/2012/08/20/daily28-InVivo-Therapeutics-scientist-gets-10K-grant.html",
    "source_text": "",
    "source_description": "InVivo Therapeutics scientist gets $10K grant",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "InVivo Therapeutics",
      "permalink": "invivo-therapeutics"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": 2010,
   "pub_month": 11,
   "pub_day": 5,
   "stock_symbol": "OTCBB:NVIV"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}